Conditions: Acute Respiratory Infection
Keywords: Acute Respiratory Infection Mucociliary Cough Clearance Guaifenesin
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 38
Healthy volunteers: no

Brief summary:
The purpose of this research study is to explore the mechanism of action of Mucinex, an oral, over-the-counter, FDA approved expectorant in patients with acute respiratory tract infections.

Detailed description:

Arms:
arm 1: Mucinex 1200mg (Guaifenesin)given as 2, 600mg tablets arm 2: Given as 2 tablets

Interventions: intervention 1: Mucinex intervention 2: Placebo
Intervention descriptions: intervention 1: Mucinex 1200mg (Guaifenesin) given as 2,600mg tablets, one time on day 1 of the study intervention 2: Placebo given as 2 tablets

Protocol document: